Healthcare
FONAR Corporation(FONR)
Live Price
Offline$19.09
+0.00% today
1Y Change
+34.91%
Window
Jun 25, 2025 โ Jun 3, 2026
- Market Cap
- $120.00M
- Revenue Growth
- +1.4%
- EPS Growth
- -19.2%
- Dividend Yield
- 0.0%
Coverage: 236 bars ยท Jun 25, 2025 โ Jun 3, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
FONAR Corporation (FONR) is a Healthcare stock with a market cap of $120.00M and listed on NASDAQ. The stock last traded around $19.09 and up 34.9% across the available one-year price window (Jun 25, 2025 โ Jun 3, 2026). Baseline metrics include revenue growth of +1.4%, EPS growth of -19.2%, a dividend yield of 0.0%. What stands out right now is revenue +1.4%, EPS -19.2%, free cash flow -43.9% with operating margin 10.1% and ROIC 4.0%. Valuation is more restrained than many high-expectation growth names at P/E 15.7 and price/sales 1.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines FONR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.4% vs +7.6% peer median
Operating Margin
Below sector median
+10.1% vs +19.4% peer median
P/E
Below sector median
15.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +1.4% and EPS is at -19.2%, with operating margin around 10.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.1% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | +0.0% | +0.4% | โ |
2026 Feb 13, 2026 | โ | -0.1% | +0.2% | -0.7% |
2025 Nov 10, 2025 | โ | -1.1% | -3.9% | -4.8% |
Benchmark Edge
FONR vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
FONR
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
FONR Max Drawdown
-13.98%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for FONR and SPY.
Company Overview
FONAR Corporation
NASDAQ Capital Market
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
- Leadership
- Timothy R. Damadian
- IPO Date
- Oct 29, 1981
- Employees
- 520
- Street Address
- 110 Marcus Drive
- Mailing
- Melville, NY, 11747
- Region
- Melville, NY, US
- Reporting Currency
- USD
- Investor Line
- 631 694 2929
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 15.7
- EV/EBITDA
- 6.3
- Price/Sales
- 1.1
- Price/Book
- 0.7
Growth
- Revenue
- +1.4%
- EPS
- -19.2%
- Free Cash Flow
- -43.9%
Profitability
- Gross Margin
- 40.8%
- Operating Margin
- 10.1%
- Net Margin
- 7.1%
- ROE
- 4.3%
- ROIC
- 4.0%
Balance Sheet
- Debt/Equity
- 0.22
- Current Ratio
- 10.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.